首页> 外文期刊>Clinical neurophysiology >A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations.
【24h】

A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations.

机译:混合的D1和D2拮抗剂不会重现选择性D2拮抗剂在正常人中观察到的模式视网膜电图改变:与帕金森氏病模式视网膜电图改变的关系。

获取原文
获取原文并翻译 | 示例
       

摘要

The human retina produces a tuned response to stimuli of increasing spatial frequency reversed at a steady state. The peak amplitude response, at medium spatial frequencies, is decreased in Parkinson's disease and in normal subjects (n = 18) treated with a D2 dopaminergic antagonist (l-sulpiride). Here, we report that a mixed D1-D2 receptor antagonist (haloperidol) in normal subjects (n = 18) does not produce an amplitude decrease of medium spatial frequencies (SFs) responses but it decreases low-frequency response. It could argued that the increased dopamine release produced by the presynaptic D2 antagonistic action of haloperidol is subsequently counteracted at postsynaptic level by its D1 antagonistic effect, producing a net counterbalance at medium SFs. These data suggest that the two dopamine receptors may play different roles in the retinal function and in the origin of visual alterations in Parkinson's disease.
机译:人体视网膜对稳定状态下反转的空间频率增加的刺激产生调谐的响应。在帕金森氏病和接受D2多巴胺能拮抗剂(1-舒必利)治疗的正常受试者(n = 18)中,中等空间频率的峰值幅度响应降低。在这里,我们报道在正常受试者(n = 18)中混合的D1-D2受体拮抗剂(氟哌啶醇)不会产生中等空间频率(SFs)响应的幅度降低,但会降低低频响应。可以认为,氟哌啶醇的突触前D2拮抗作用所产生的增加的多巴胺释放随后在突触后水平被其D1拮抗作用所抵消,从而在中等SF处产生净平衡。这些数据表明,两种多巴胺受体可能在帕金森氏病的视网膜功能和视觉改变的起源中发挥不同的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号